Clinical Trial Update: The Role of TLR4 on Lipid-induced Insulin Resistance [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the role of TLR4 in lipid-induced insulin resistance; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Insulin Sensitivity Disorders

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Insulin Sensitivity | Phase 2 | Status: COMPLETED | Results posted: 2019-10-08